Impact of CRISP on Self-Efficacy, Loneliness, and Depression

NYU Langone Health

Status: Completed

Conditions: Multiple Sclerosis

Treatments: Behavioral: CRISP Program; Other: Control Group

Study type: Interventional

Funder types: Other

Identifiers

NCT02030197

S14-00572

Details and patient eligibility

About

The purpose of this study is to examine the effects of an innovative program, entitled CRISP (Community Integration for Socially Isolated Patients), on improving self-efficacy and assessing whether improved self-efficacy helps to reduce depression and loneliness of people with MS.

Full description

Whether CRISP increases self-efficacy while decreasing loneliness and depression

Enrollment: 118 patients

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age 18 to 65 years old.
• Must have a definitive diagnosis of MS by a physician.
• Must understand English at 6th grade level since the CRISP program requires participants to comprehend the educational information presented in English.
• Agree to participate in 12 group sessions over 12 weeks;
• Must have the ability to complete questionnaires in English since the outcome measures used for the study are in English.
• Must be able to commute to the site destinations

Exclusion criteria

• Have an actively psychotic Axis I disorder.
• Have a significant Axis II disorder of borderline personality disorder or schizoid personality disorder.
• Have a diagnosis of another neurological condition aside from MS.
• Inability to comply with study requirements/visits.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

118 participants in 2 patient groups, including a placebo group

CRISP program

Active Comparator group

Description:

educational and socialization program

Treatment:

Behavioral: CRISP Program

Control Group

Placebo Comparator group

Description:

no treatment control group

Treatment:

Other: Control Group